Physician profile
Amanda Reed
NPI 1194165258
$5,500.17
in general payments reported to CMS, 2019-2025
10 companies · $4,229 in 2025
The $4,229 reported for 2025 was more than what 95% of Addiction Medicine (Family Medicine) providers received nationally (typical 2025 total: $143).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32.05 · 2020: $41.78 · 2021: $268 · 2022: $93.85 · 2023: $608 · 2024: $228 · 2025: $4,229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,328 · Food and Beverage: $1,636 · Travel and Lodging: $1,101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,328.00 |
| Food and Beverage | $1,635.54 |
| Travel and Lodging | $1,101.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $4,038.03 | 2021-2025 | Sublocade |
| Gilead Sciences, INC. | $392.40 | 2023-2025 | Epclusa, Biktarvy |
| Abbvie INC. | $275.13 | 2023-2024 | |
| Alkermes, INC. | $227.06 | 2021-2025 | Vivitrol |
| Viiv Healthcare Company | $218.54 | 2022-2025 | Cabenuva, Apretude, Dovato |
| Braeburn INC. | $172.72 | 2024-2025 | Brixadi |
| Abbott Laboratories | $75.22 | 2020-2021 | |
| Janssen Scientific Affairs, LLC | $41.47 | 2021 | |
| Janssen Pharmaceuticals, INC | $41.26 | 2019-2021 | |
| Amgen INC. | $18.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Reed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.